Cargando…

Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union

Background: nasal or oral sprays are often marketed as medical devices (MDs) in the European Union to prevent common cold (CC), with ColdZyme(®)/Viruprotect(®) (trypsin/glycerol) mouth spray claiming to prevent colds and the COVID-19 virus from infecting host cells and to shorten/reduce CC symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Huijghebaert, Suzy, Vanham, Guido, Van Winckel, Myriam, Allegaert, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150360/
https://www.ncbi.nlm.nih.gov/pubmed/34064793
http://dx.doi.org/10.3390/ijerph18105066